ArticleBreast cancer research and treatment2025

Dual targeting of HSP90 and BCL-2 in breast cancer cells using inhibitors BIIB021 and ABT-263.

Nazan Gökşen Tosun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.